Empowering Biopharma Innovation @ ASGCT 2026 Boston

Boston 2026: Witnessing the "Industrial Evolution" of CGT

In May 2026, the global Cell and Gene Therapy (CGT) community will once again converge on Boston. As the one of world’s most influential industry gathering, ASGCT 2026 is not only the premier stage for groundbreaking research but also the definitive bellwether for the future of biopharma.

This year’s conference highlights the shift toward mature industrialization:

  • Manufacturing & Automation: Moving beyond the lab—how to achieve robust, commercial-scale production.

  • Non-viral Delivery: Optimizing mRNA-LNP platforms for enhanced safety and long-term stability.

  • Next-Gen AAV Technology: Breaking the yield bottleneck and mastering Empty/Full ratio control.

  • In Vivo Gene Editing: Advancing CRISPR and other tools toward clinical translation with precision quality control.

Yeasen is proud to showcase our core CGT reagent solutions at Booth 1065. Being part of the '2026 ASGCT VIP Executive Delegation' is about more than just exhibiting; it’s an opportunity to immerse ourselves in Boston’s innovation ecosystem. Through our engagement with industry pioneers like Voyager and Arbor, we incorporate the latest insights and highest global quality standards directly into our product development.

📅 Pre-Event Exclusive: Book Your 1v1 Technical Talk

To maximize the value of your Boston visit, we have opened the "Pre-event 1v1 Technical Consultation" booking channel.

  • The Focus: Discuss how customized enzyme engineering or process optimization can help your pipeline achieve higher quality, lower costs, and increased efficiency.

  • The Benefit: Secure a dedicated timeslot to skip the booth crowds and dive deep into technical troubleshooting and global expansion strategies with our senior scientists.

  • How to Book: [Click Here ] to submit your research interests and secure your session.

🔬 Booth 1065: Solving Core Challenges in CGT Manufacturing

We cordially invite you to visit us and explore how raw material innovation can empower your drug development:

🧬 mRNA Synthesis: Reduced Immunogenicity

Featured Product: 

Technical Value: Low-dsRNA T7 RNA Polymerase produces less immunogenic mRNA.

Through advanced enzyme engineering, we have successfully suppressed dsRNA byproduct formation at the source during IVT. This significantly reduces non-specific immune responses and enhances translation efficiency, providing a more robust foundation for the clinical performance of mRNA therapies.

🧬 AAV Manufacturing: Competitive Cost Structure

Featured Product: 

Technical Value: Superior Transfection Solution cuts AAV manufacturing costs.

In large-scale AAV production, transfection efficiency dictates yield and unit cost. Yeasen’s optimized solution is designed to reduce the consumption of expensive plasmids and reagents while maintaining exceptionally high viral titers, helping biopharma companies establish a cost advantage in an increasingly competitive market.

🌐 Yeasen in Boston: From Technical Supply to Global Synergy

Beyond the exhibition at Booth 1065, our technical and strategic teams will be active across the Boston ecosystem:

  • Strategic Networking: Engaging with the Broad Institute, Harvard Medical School, and other top-tier institutions to anticipate global regulatory and technical trends.

  • Global Quality Standards: Sharing Yeasen’s experience in supporting International Multi-Center Clinical Trials (IIT) and global regulatory filings.

  • Regulatory Readiness (DMF Filed): Providing raw materials and reagents backed by active FDA Drug Master File (DMF) registrations, designed to accelerate your IND applications and simplify global compliance.

  • Co-Innovation: Discussing how our customized enzyme engineering services can be tailored to match your specific platform requirements.

Join us at the Thomas M. Menino Convention Center, May 11–15. 🚀 Discover how Yeasen’s innovative reagents empower the global biopharma pipeline. We look forward to seeing you at Booth 1065!

Additional Information

Forespørgsel